Auranofin C₂₀H₃₄AuO₉PS

Therapeutic indications

Auranofin is indicated for:


Population group: both men and women, only adults (18 years old or older)

at least one of
Seropositive rheumatoid arthritis

Other rheumatoid arthritis

Ankylosing spondylitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Auranofin is contraindicated in the following cases:


at least one of
Hepatic insufficiency

Renal failure




Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.